BRPI1009468A2 - formulações galênicas de compostos orgânicos - Google Patents

formulações galênicas de compostos orgânicos

Info

Publication number
BRPI1009468A2
BRPI1009468A2 BRPI1009468A BRPI1009468A BRPI1009468A2 BR PI1009468 A2 BRPI1009468 A2 BR PI1009468A2 BR PI1009468 A BRPI1009468 A BR PI1009468A BR PI1009468 A BRPI1009468 A BR PI1009468A BR PI1009468 A2 BRPI1009468 A2 BR PI1009468A2
Authority
BR
Brazil
Prior art keywords
organic compounds
galenic formulations
galenic
formulations
compounds
Prior art date
Application number
BRPI1009468A
Other languages
English (en)
Inventor
Hong Wen
Indrajit Ghosh
Shoufeng Li
Sudha Vippagunta
Wei-Qin Tong
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI1009468A2 publication Critical patent/BRPI1009468A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI1009468A 2009-03-20 2010-03-18 formulações galênicas de compostos orgânicos BRPI1009468A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16189109P 2009-03-20 2009-03-20
PCT/US2010/027757 WO2010107971A1 (en) 2009-03-20 2010-03-18 Galenical formulations of a fixed dose combination of valsartan and aliskiren

Publications (1)

Publication Number Publication Date
BRPI1009468A2 true BRPI1009468A2 (pt) 2016-03-01

Family

ID=42594917

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009468A BRPI1009468A2 (pt) 2009-03-20 2010-03-18 formulações galênicas de compostos orgânicos

Country Status (13)

Country Link
US (1) US20120009257A1 (pt)
EP (1) EP2408427A1 (pt)
JP (1) JP2012520895A (pt)
KR (1) KR20110130491A (pt)
CN (1) CN102348452A (pt)
AR (1) AR075880A1 (pt)
AU (1) AU2010226620A1 (pt)
BR (1) BRPI1009468A2 (pt)
CA (1) CA2755487A1 (pt)
MX (1) MX2011009846A (pt)
RU (1) RU2011142081A (pt)
TW (1) TW201039866A (pt)
WO (1) WO2010107971A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201701448XA (en) * 2014-08-29 2017-03-30 Duchesnay Inc Plurimodal release formulation of doxylamine and pyridoxine and/or metabolites or salts thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
MY144477A (en) 2004-03-17 2011-09-30 Novartis Ag Galenic formulations of organic compounds
AR066168A1 (es) * 2007-09-28 2009-07-29 Novartis Ag Formulaciones galenicas de compuestos organicos
EP2205279B1 (en) * 2007-09-28 2011-04-13 Novartis AG Pharmaceutical combination of aliskiren and valsartan
WO2009040427A1 (en) * 2007-09-28 2009-04-02 Novartis Ag Galenical formulations of organic compounds
AR073651A1 (es) * 2008-09-24 2010-11-24 Novartis Ag Formulaciones galenicas de compuestos organicos
US20120003308A1 (en) * 2009-03-20 2012-01-05 Sonali Bose Pharmaceutical Composition Comprising Aliskiren
US9959508B2 (en) 2014-03-20 2018-05-01 CloudMade, Inc. Systems and methods for providing information for predicting desired information and taking actions related to user needs in a mobile device

Also Published As

Publication number Publication date
JP2012520895A (ja) 2012-09-10
CN102348452A (zh) 2012-02-08
CA2755487A1 (en) 2010-09-23
KR20110130491A (ko) 2011-12-05
US20120009257A1 (en) 2012-01-12
AU2010226620A1 (en) 2011-09-22
TW201039866A (en) 2010-11-16
MX2011009846A (es) 2011-09-29
WO2010107971A1 (en) 2010-09-23
EP2408427A1 (en) 2012-01-25
RU2011142081A (ru) 2013-04-27
AR075880A1 (es) 2011-05-04

Similar Documents

Publication Publication Date Title
BRPI1007452A2 (pt) formulações galênicas de compostos orgânicos
BRPI0817442A2 (pt) Formulações galênicas de composto orgânicos
HRP20181347T1 (hr) Formulacije dvoslojne tablete
BRPI1012247A2 (pt) compostos inseticidas
SMT201600008B (it) Composti di piridazinone
BRPI1015931A2 (pt) Compostos inseticidas
PT2448582T (pt) Compostos e composições terapêuticas
LT3403654T (lt) Geriamosios kortikosteroido kompozicijos
LT3061445T (lt) Labai koncentruotos farmacinės kompozicijos
BRPI1013614A2 (pt) compostos substituídos de espiro-amida
BRPI1012539A2 (pt) composições farmacêuticas
BRPI0715621A2 (pt) Formulações galênicas de compostos orgânicos
BRPI1009465A2 (pt) Formulação
PT2260053E (pt) Análogos de oxitocina
BR112012003868A2 (pt) Compostos orgânicos
BRPI1013941A2 (pt) compostos inseticidas
HUE052508T2 (hu) Szerves anyagból származó illékony szerves vegyületek elnyelése
IT1394400B1 (it) Composizioni farmaceutiche
SMT201600031B (it) Composti eterociclici di fenossimetile
PT2402012E (pt) Formulações líquidas de fumarato de rupatadina
BRPI0917210A2 (pt) exoterma controlada de formulações de cianocrilato
SMT201500268B (it) Derivato di 5-idrossipirimidin-4-carbossammide
EP2404987A4 (en) PERFUME COMPOSITIONS
SMT202100150T1 (it) Formulazioni migliorate
BR112012001340A2 (pt) composições farmacêuticas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]